Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations

Lignende værker

• Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway
  af: Conti, Annalisa, et al.
  Udgivet: (2015)
• Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines
  af: Weißbach, Susann, et al.
  Udgivet: (2020)
• Oncogenic Kras Requires Simultaneous PI3K Signaling to Induce ERK Activation and Transform Thyroid Epithelial Cells in Vivo
  af: Miller, Kelly A., et al.
  Udgivet: (2009)
• EZH2 Protein Expression Associates With the Early Pathogenesis, Tumor Progression and Prognosis of Non-small Cell Lung Carcinoma
  af: Behrens, Carmen, et al.
  Udgivet: (2013)
• Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
  af: Catalano, Antonella, et al.
  Udgivet: (2021)